Insights On Partnering
-
Pursuing Breakthrough Therapies For Rare Metabolic Diseases
2/14/2024
Explore how a comprehensive clinical trial team expertly coordinated the dosing administration and data review for gene therapy, ensuring meticulous management and streamlined processes.
-
Partnering With An Integrated CRO/CDMO: 5 Things You Need To Know
1/9/2024
Sponsors always ask, “Will the partnership save me time and money?” and “How can you streamline the complex development processes for me?” Get the answers to these questions and more.
-
Maximizing Efficiency And Cost Savings In Life Sciences
5/16/2024
Discover how NetSuite's tailored ERP solutions, combined with Sikich's implementation expertise, streamline operations and navigate industry complexities to drive long-term success.
-
Effective & Efficient Clinical Trial Site Financial Management
10/24/2024
The financial management aspects of clinical research sites are crucial to maintaining profitability. In this text, we outline three pivotal areas your site will need to address.
-
Navigating Autoimmune Disease A Playbook For Cell And Gene Therapies
9/3/2025
By integrating site readiness, patient engagement, and data-driven decision-making, the cell and gene therapies (CAGT) field is advancing toward therapies that not only control disease but transform lives.
-
An Introduction To One Home for Sites™
4/18/2024
This on-demand webinar provides a thorough overview of why IQVIA Technologies is building One Home for Sites, how it works, and who should participate.
-
Biotech Delivers A Superior Patient And Site Experience
3/4/2025
To become the sponsor of choice for sites and patients in congenital hyperinsulinism clinical trials, a small biotech company prioritized delivering a superior experience while streamlining operations.
-
A Deeper Dive On Mitigating Financial Risk Before Selecting A Vendor
1/23/2024
In part two of this webinar series, presenters focus on avoiding potential risks, such as unexpected budget changes and unplanned change orders, that could jeopardize the success of a clinical trial.
-
Accelerated Development: Gene Therapy Vs. Small Molecule
12/26/2023
Combined with the inherent difficulty of the chemistry behind gene therapy development, its pace, structure, and funding dynamics are unique among treatment modalities.
-
TPDs: Developing The Next Generation Of Oral Therapeutics
10/20/2025
Targeted Protein Degraders are a revolutionary drug class with challenges in bioavailability and formulation complexity. Strategic CDMO partnerships are key to successful, scalable development.